Without etching, the height of the area pre-this website processed at 10-μN load was lower than that at 40 μN. When the KOH solution etching time was increased, A-B was nearly 3 nm until 20 min. The heights of the areas were similar in value at 25 min. In contrast, at 30- and 35-min etching time, the height of the 10-μN load area was higher than that at 40 μN. These results show that the etching rate of the area pre-processed at 40-μN load was larger than that at 10 μN. This is deduced to be because the area pre-processed with plastic deformation at 40-μN load was more easily etched due

to damage compared with the uniform protuberance pre-processed at 10 μN.Figure  15 shows a model of etching depth dependence on KOH solution etching time for pre-processed areas. GW-572016 supplier click here As shown in Figure  15b, with an increase of etching time, by the removal of the natural oxide layer, the 1.5-μN-load pre-processed area was etched at first. The etching rate increased with KOH solution etching time under processing at low load and scanning density.However, as shown in Figure  15c, the two areas processed at higher load and

scan density were not etched because of their thick oxide layers. These thick oxide layers, which were mechanochemically formed on the areas processed at higher load, prevented the KOH solution etching and thereby decreased the etching rate. From these results, the etching rate is controllable by the removal of the natural oxide layer and direct oxidation by mechanical action. Grooves with various depths can be obtained using this etching rate control. Figure 15 Model of the increasing and decreasing of etching rate. (a) Change to surface profile by mechanical processing. (b) Change to surface profile by KOH solution etching (25 min). (c) Change to surface profile by KOH solution etching (40 min). Conclusions To realize the nanofabrication

of a Si substrate, the etching depths obtained with KOH solution were controlled using mechanical pre-processing under various loads and scanning density conditions. Removal and formation of the oxide etching mask was performed on silicon surfaces 3-oxoacyl-(acyl-carrier-protein) reductase using atomic force microscopy. Areas mechanically pre-processed at 1- to 4-μN load exhibited an increased KOH solution etching rate due to the removal of the natural oxide layer by the mechanical action. The dependence of etching depth on pre-processing load and scanning density was clarified. At every scanning density, there were certain load ranges within which the etching depth increased. In contrast, protuberances with a thick oxide layer produced by mechanical pre-processing at higher load suppressed etching. This mechanochemical oxide layer had superior etching resistance to that of the natural oxide layer. Protuberances were processed on the Si surfaces under stress conditions both lower and higher than that where plastic deformation occurs. These processed areas were hardly etched by the KOH solution.

CrossRef 6. Reda SM: Synthesis of ZnO and Fe 2 O 3 nanoparticles by sol–gel method and their application in dye-sensitized

solar cells. Mater Sci Semicond Process 2010, 13:417–425.CrossRef 7. Zhang S, Chen X, Gu C, Zhang Y, Xu J, Bian Z, Yang D, Gu N: The effect of iron oxide magnetic nanoparticles on smooth muscle cells. Nanoscale Res Lett 2009, 4:70–77.CrossRef 8. Kallumadil M, Tada M, Nakagawa T, Abe M, Southern P, Pankhurst QA: Suitability of commercial colloids for magnetic hyperthermia. J Magn Magn Mater 2009, 321:1509–1513.CrossRef 9. Thapa D, Palkar VR, Kurup MB, Malik SK: selleck Properties of magnetite nanoparticles synthesized through a novel chemical route. Mater Lett 2004, 58:2692–2694.CrossRef 10. Zhang D, Liu Z, Han S, Li C, Lei B, Stewart MP, Tour JM, Zhou C: Magnetite (Fe 3 O 4 ) core-shell nanowires: synthesis and magnetoresistance. Nano Lett 2004, 4:2151–2155.CrossRef 11. Yu MK, Jeong YY, Park J, Park S, Kim JW, Min JJ, Kim K, Jon S: Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed 2008, 47:5362–5365.CrossRef

12. Zeng H, Li J, Liu JP, Wang ZL, Sun S: Exchange-coupled nanocomposite magnets by nanoparticle self-assembly. Nature 2002, 420:395–398.CrossRef 13. Kay A, Cesar I, Gratzel M: New benchmark for water photooxidation by nanostructured α-Fe 2 O 3 films. J Am Chem Soc 2006, 128:15714–15721.CrossRef 14. Karunakaran C, Anilkumarl P: Semiconductor-catalyzed Crenolanib solar photooxidation of iodide ion. J Mol Catal A Chem 2007, 265:153–158.CrossRef 15. Geng BY, Ma JZ, You JH: Controllable synthesis of single-crystalline Fe 3 O 4 polyhedra possessing the active basal facets. Cryst Growth Des 2008, 8:1443–1447.CrossRef 16. Zhang GY, Xu YY, Gao DZ, Sun YQ: α-Fe 2 O 3 nanoplates: PEG-600 assisted hydrothermal synthesis and formation mechanism. J Alloys Compd 2011, Branched chain aminotransferase 509:885–890.CrossRef 17. Yin W, Chen X, Cao M, Hu C, Wei B: α-Fe 2 O 3 nanocrystals: controllable SSA-assisted hydrothermal synthesis, growth mechanism, and magnetic properties. J Phys Chem C 2009, 113:15897–15903.CrossRef 18. Liu L, Kou HZ, Mo W, Liu H, Wang Y: Surfactant-assisted

synthesis of alpha-Fe 2 O 3 nanotubes and nanorods with shape-dependent magnetic properties. J Phys Chem B 2006, 110:15218–15223.CrossRef 19. Nasibulin AG, Rackauskas S, Jiang H, Tian Y, Mudimela PR, Shandakov SD, Nasibulina LI, Sainio J, Kauppinen EI: Simple and rapid synthesis of α-Fe 2 O 3 nanowires under ambient conditions. Nano Res 2009, 2:373–379.CrossRef 20. Ramesh R, Ashok K, Bhalero GM, Ponnusamy S, BMN 673 cell line Muthamizhchelvan C: Synthesis and properties of α-Fe 2 O 3 nanorods. Cryst Res Technol 2010, 45:965–968.CrossRef 21. Zhang Z, Hossain MF, Takahashi T: Self-assembled hematite (α-Fe 2 O 3 ) nanotube arrays for photoelectrocatalytic degradation of azo dye under simulated solar light irradiation. Appl Catal B Environ 2010, 95:423–429.CrossRef 22.

Finally, two selleck compound strains from women with mastitis (CJ11 and DG2S) were resistant to streptomycin (> 1000 μg mL-1) and one strain (AQLI2) from the same group was resistant to vancomycin (16 μg mL-1). No strains resistant to these two antibiotics were found among the strains from healthy women. Table 2 Distribution of MIC’s to several antibiotics amongS. epidermidisisolated from mastitis and healthy women       Percentage of strains for which the MIC (μg mL-1) was as follows: Antibiotics Breast milk N° of strains ≤ 0.03 0.12 0.25 0.5 1 2 4

8 > 8   PEN H 36 17 8   8 14 14 8 11 19     M 40 10 5 5 8 10 33 8 8 18   AMP       ≤ 0.12 0.25 0.5 1 2 4 8 100 > 100   H 36   19 6 17 22 8 8 6 14     M 40 buy MM-102   15 8 5 23 20 10 5 13 3 OXA         ≤ 0.25 0.5 1 2 > 2         H 36     11 31 11 8 39         M 40     5 8 13 8 68       CIP         ≤ 0.25 0.5 1 2 > 2         H 36     47 39 8   6         M 40     30 38 18 3 13       CHL                   ≤ 8 16 > 16   H 36               75 17 8   M 40               78 10 13 ERY         ≤ 0.25 0.5 1 2 4 > 4       H 36     39 14 6 8   33       M

40     23 15     3 60     CLI           ≤ 0.5 1 2 > 2         H 36       81 8 3 8         M 40       70 3   28       TET                 ≤ 4 8 > 8     H 36             56 19 25     M 40             68 8 25   VAN           ≤ 0.5 1 2 4 8 16 ≥ 16   H 36         44 50 6         M 40         43 48 5 3 3   MUP                 ≤ 4 256 > 256     H 36             78 11 11     M 40             58 13 30   H: strains

isolated from healthy women; M: strains isolated from mastitis-suffering women; PEN: penicillin; AMP: ampicillin; OXA: oxacillin; CIP: MK-0457 order ciprofloxacin; Dolutegravir CHL: chloramphenicol; ERY: erythromycin; CLI: clindamycin; TET: tetracycline; VAN: vancomycin; MUP: mupirocin. Statistically-significant differences between isolates from mastitis and healthy women are in bold. Presence ofmecAand SCCmectyping Among the 41 strains showing oxacillin resistance, themecA gene could be detected by PCR in 37 (25 from mastitic milk and 12 from milk of healthy women). No amplification was observed in two strains of each group (F12 and CJ9; LI5081 and LC047, respectively), which had shown an oxacillin MIC value of > 2 μg mL-1. In contrast, themecA gene was detected in five oxacillin susceptible strains, one from a mastitis case (YLIC13) and four from healthy women (LO5RB1, LX5RB3, LV221 and LCC5082). The type of SCCmecwas determined in all themecA+strains. TheccrB gene could be amplified from 22 of the 26mecA+strains from the mastitis group and, on the basis of theccrB restriction pattern withHinfI (type IV: 264, 227 and 154 bp; type III: 537 and 106 bp) or withHinfI/BsmI (type IV: 227, 171, 153 and 93 bp; type III: 320, 174, 106 and 44 bp), 19 strains were assigned to type IV and the remaining three (S1LDC12, Z2LDC17 and DF2LAB) to type III (see additional file 1).

2007). The increase in sickness absence due to common mental disorders (CMDs), in particular depression, Fedratinib manufacturer anxiety disorders, and stress-related disorders, is higher than for other disorders (Alexanderson and Norlund 2004; Vaez et al. 2007), and symptoms of depression and anxiety

have been shown to predict disability pension in Norway and Denmark (Mykletun et al. 2006; Bültmann et al. 2008). In the United Kingdom, sickness absence due to mental disorders is nowadays the major cause of sick leave, accounting for almost 40% of all sickness absence (Shiels et al. 2004). Few studies have investigated characteristics of sickness absence due to mental disorders (Hensing and Wahlstrom 2004). The most consistent finding was that women were more frequently sick-listed due to mental disorders than men. However, even though mental disorders are more common among women, sickness absence seems to be longer among male employees

with mental disorders than among female employees (Hensing et al. 2000; Laitinen-Krispijn and Bijl 2000). Vaez et al. (2007) found that 65% of the employees with long-term sickness absence due to mental disorders had high levels of sickness absence in the three following years. Although EPZ015938 molecular weight the recurrence rate of mental disorders is assumed to be high (Mueller et al. 1999; Crown et al. 2002; Keller 2002; Yonkers et al. 2003; Robinson and Sahakian 2008), the recurrence of sickness absence due to CMDs has not yet been studied. Therefore, in this study we addressed the following research questions: 1. ZD1839 What is the recurrence of sickness absence due to CMDs,

and the median time to recurrence?   2. Which determinants are related to the recurrence of sickness absence due to CMDs?   Methods Study population and study design This study was based on a cohort consisting of 9,904 employees who have had an episode of sickness absence due to a medically certified CMD. The cohort was drawn from a population of employees working in the Dutch Post and Telecommunication company in the period 2001–2007. The total population consisted of 137,172 employees (62% men and 38% women). Approximately 70% of the employees worked in the Post company and 30% in the Telecommunication company. Their main work tasks included sorting, transport and delivery of mail, post office activities and back-office, technical, sales, information technology, and executive tasks. Data on sickness absence in the years 2001 through 2007 were collected retrospectively from the records of the ArboNed Occupational Health Services. The Medical Ethics Committee of the University Medical Center in Groningen informed us that ethical approval was not required because the data were CRT0066101 mouse analyzed in retrospect at group level.

On the basis of the previous analysis, we proposed a reasonable mechanism for the

formation of ZnO structures. It is believed that sodium citrate is extensively used as the stabilizer and structure-directing agent because of its excellent adsorption ability [28, 29]. The additive citrate can form strong complexes [Zn(C6H5O7)4]10− with Zn2+ and owing to the stability of [Zn(C6H5O7)4]10− which is larger than [Zn(OH)4]2− in the present situation, there exists a large selleck quantity of [Zn(C6H5O7)4]10− with negative charge and a small quantity of [Zn(OH) 4]2− in the precursor solution. It has been previously reported that citrate anions have been known to act as a capping agent of the (0001) surface of the ZnO crystal by adsorbing on the positive polar face

of the (0001) surface [30, 31]. Thus, these [Zn(C6H5O7)4]10− ions are preferred to absorb positive polar plane (0001) surface through the -COO− and -OH functions, and decrease the growth rate of (0001) ZnO crystal surface by competing with growth units [Zn(OH)4]2−, which limits the anisotropy growth of ZnO at experimental pH value and leads to the formation of lamina-like ZnO nanostructures, as shown in Figure  1a,b. The stacking of the laminas is not completely ordered, and the drug discovery laminas’ self-assembly at a later time is progressively more tilted leading to the formation of petal-like, flower-like, nestlike, clew-like, and spherical aggregates for adjusting the electrodeposition time and the concentration of sodium citrate. It is worth mentioning that the morphologies of the products varied remarkably with the concentration of citrate. On the basis of the experiment selleck inhibitor results, we found that when the concentration of citrate was lower than 0.05 mmol (0.01 mmol in Figure  1e,f), the nascent square nanolaminas would self-assemble from bottom to top to form nestlike structures.

On the other way around, when the concentration of citrate was higher than 0.05 mmol (0.1 mmol in Figure  1d,l,n), the nascent nanolaminas would self-assemble from center outwards to generate flower-like Flucloronide or microsphere structures. It has been reported that high citrate concentration (higher than 0.05 mmol) will attain [Zn(C6H5O7)4]10− supersaturated solution and Ostwald ripening controls structure growth by the diffusion of [Zn(C6H5O7)4]10− ions along the matrix-particle boundary tending to form spherical/hemispherical shapes from the center [32, 33]. In contrary to this, the lower citrate concentrations will not form [Zn(C6H5O7)4]10− supersaturated solution, which tend to self-assemble from bottom to top.

A.3). However, in 2.A.3, all recognized members of this family were initially included under 2.A.3. This is a historical fact that cannot be readily corrected because the IUBMB and UniProt require a stable system of classification. Subsequently, we could show that other families previously existing in TCDB were members

of this superfamily. The same was true for the MFS. Thus, we call what would normally be called “subfamilies” the families for both the MFS (2.A.1) and the APC (2.A.3). The same is true for the ABC functional superfamily, except that the membrane proteins actually comprise three superfamilies, ABC1, ABC2 and ABC3 as discussed above [16]. 3 The numbers in bold indicate comparison scores expressed Go6983 price in S.D [16]. Non-bolded numbers are the exponential numbers (e-values) obtained with TC-BLAST. For instance,

the number “12” in the first row of column 12 indicates that the comparison score between 1.6 CymF and 20.1 BitE was e-12. The TC# provided is the family/protein number (e.g. 1.1 for MalF and MalG, the two membrane constituents of the E. coli maltose transporter). The first three digits in the TC# (3.A.1.) refer to the ABC functional superfamily and are not shown. They are the same for all entries. The protein TC# is followed by the protein abbreviation. All members of a single family are demonstrably homologous, giving high comparison scores (greater than 15 S.D.). Any two families for which a number is provided in the table below learn more are demonstrably homologous based on the criteria stated in the Methods Adenosine triphosphate section. All proteins are within the ABC superfamily (3.A.1), but only the family and protein TC#s are provided below, e.g. 1.6 means 3.A.1.1.6, i.e., ABC family 1, member 6. Topological analyses of ABC uptake system ABC uptake systems, found only in prokaryotes and chloroplasts, contain porters of diverse topological types, and in this section we attempt to predict these topologies. Our studies, reported below, allow us to propose that the primordial transporter contained three TMSs, which see more duplicated internally to give six TMS homologues [1]. As demonstrated

here, membrane constituents of ABC uptake systems except those of family 21 are of the ABC2 type. However, the actual transporters appearing on the TCDB website contain various numbers of TMSs that range from four or five to twenty. For some families of uptake systems such as families 1, 3 and 14, the porters are more topologically diverse than those from other families such as 8, 11 and 17. Table 2 presents these families and summarizes the topological types predicted for members of uptake porter families. Table 2 Predicted topologies for members of the 34 families of uptake porters in the ABC superfamily (TC# 3.A.1) 1   Family name No. of membrane proteins in TCDB No. of membrane proteins/system Average predicted #TMSs No. of predicted TMSs for family members.

This richness is considerably higher than the 34 to 72 phylotypes and the 6 to 30 genera previously described using conventional cloning and sequencing [15, 16]. The predominant taxa belonged to Firmicutes (genus Streptococcus, family Veillonellaceae, genus

Granulicatella), Proteobacteria (genus Neisseria, Haemophilus), Actinobacteria (genus Corynebacterium, Rothia, Actinomyces), Bacteroidetes (genus Prevotella, Capnocytophaga, Porphyromonas) and Fusobacteria (genus Fusobacterium) (Additional file 4). Figure 2 The relative abundance of OTUs per individual. Relative abundance of OTUs based on all unique sequences (0%, solid lines) and OTUs within genetic distances that do not exceed 3% difference (3%, dashed lines) per individual S1, S2 and S3, respectively. The x-axis indicates the individual OTUs, ranked according to their relative abundance (high MCC950 cell line to low). The S3I-201 y-axis indicates the cumulative abundance of the OTUs. About 100 “”species-level”" phylotypes (118, 97 and 112 phylotypes in the microbiome of individual S1, S2 and S3, respectively) belonged to abundant OTUs of the individual microbiome (Additional file 1). A phylotype was considered abundant if it contributed to at least 0.1% of the microbiome. These abundant phylotypes together contributed to 92 – 93% of each microbiome. As with a pooled oral microbiome [4] and

individually see more sequenced gut microbiomes [13], each individual oral microbiome in this study was dominated by a few sequences while most sequences were rare and contributed to the “”long tail”" effect (Figure 2). Overlap of three individual oral microbiomes Unique sequences Twenty-six percent (1660 sequences) of the unique sequences were found in all three microbiomes and 65% in at least

two microbiomes (Figure 3A). Of all reads, 66% belonged to sequences that were shared by three microbiomes (Table 2). Nine sequences were highly abundant (0.5 – 5.8% of the reads) across all individuals: they contributed to 11%, 9% and 21% of the microbiome of individuals S1, S2 and S3, respectively (the full list of the taxonomy and abundance of the overlapping sequences is given in Additional file 5). Two of these sequences were assigned to the genus Streptococcus, two to the family Veillonellaceae, one each to the genera Granulicatella (Firmicutes), Corynebacterium, Rothia (Actinobacteria), Porphyromonas check (Bacteroidetes) and Fusobacterium (Fusobacteria). Figure 3 The extent of overlap of oral microbiome between three individuals. The extent of overlap between subjects S1 (pink circle), S2 (light blue circle) and S3 (yellow circle) at the level of A) unique sequences, B) OTUs clustered at 3% difference and C) higher taxa (genus or more inclusive taxon). The data was obtained by combining all samples of the respective individual microbiome. The Venn Diagrams show that 26% of the unique sequences, 47% of the OTUs and 72% of the higher taxa were common (area in grey) to the three individuals.

Typhimurium strains were highly attenuated and conferred protection from further challenges of wild-type S. Typhimurium by eliciting O-antigen specific serum IgG and secretory Crenolanib mw IgA in C57BL/6 mice [34–36]. In a recent study, the ssaV mutant of S. Typhimurium was found to be virulent in immune compromised C57BL/6 mice devoid of Nos2 and Il-10 gene [37]. These two mice strains were used as they lack key elements

of the antibacterial defense like the inducible nitric oxide (NO) synthase, a reactive oxygen species generating enzyme and interleukin-10 gene [38]. In this study, we have also used CD40L KO mice to screen the attenuation of proposed vaccine strain. This particular mouse model is used as it is partially immunocompromised in terms of generation of different class of antibodies. Virulence of TTSS-2 deficient S. Typhimurium in immunocompromised mice unveils the role of other factors favoring the replication and long-term survival of S. Typhimurium in host tissues. Mig-14, an antimicrobial peptide resistance protein, is one such important factor that supports the long-term persistence of Salmonella in the macrophages [39]. Mig-14 protein binds to the anti-microbial peptides like selleck products CRAMPS to protect Salmonella from antimicrobial peptides

[40]. The EPZ-6438 clinical trial presence of Mig-14 in the periplasmic localization inhibits the entry of antimicrobial peptides to the cytoplasm of the bacterium, eventually making macrophage a good niche for Salmonella to replicate check details and survive. This study proposes a diverse role for mig-14 in the survival of TTSS-2 deficient Salmonella in immunocompromised mice like Nos2 −/− , Il-10 −/− and CD40L −/− and explores the possible potential of S. Typhimurium ssaV and mig-14 double mutant as a safe vaccine carrier strain. Methods Bacterial strains and plasmids Streptomycin resistant S. Typhimurium

SB300 and Salmonella Enteritidis P125109 (S. Enteritidis) strains were taken as the wild-type controls [41, 42]. Mutants MT5 (SB300; ΔssaV) and MT4 (SB300; ΔssaV, Δmig-14) were generated by lambda red-mediated recombinase process [43]. Briefly, the host bacterial strain to be mutated was transformed with plasmid pKD46 and induced with arabinose (10 mM). The kanamycin open reading frame was PCR-amplified from template plasmid pKD4 using gene specific knockout primers (Table 1). The cassette was introduced into host bacterial genome with the help of Exo, Bet and Gam proteins from induced pKD46 plasmid of host bacterial strain. The positive mutants were selected on LB agar plates supplemented with kanamycin (50 μg/ml) and mutation in the target gene was confirmed using gene specific confirmatory primers in combination with respective forward knock-out primer (Table 1). Later, the antibiotic cassette was flipped by plasmid pCP20 [43]. An ampicillin resistant plasmid (pM973) was used to maintain the ampicillin resistant trait in wild-type strain (SB300) while challenging vaccinated mice groups with wild-type S. Typhimurium [44].

Patients and Methods This two centers study was carried out during the period from December 2000 to December 2009. Data of pediatric patients with suspected acute appendicitis who underwent the clinical judgment and US score aided CGPS were reviewed; this data was published before [1]. This was a modification of previously published scoring methods [2, 3] including certain subjective

clinical parameters measured as 1 point such as fever of 38, anorexia and vomiting, tachycardia of more than 120 beats/minute. Abdominal pain parameters were also measured with special emphasis on guarding or rigidity, positive TPCA-1 per-rectal examinations, however, positive rebound tenderness was given 3 points in this score method as well as other clinical, laboratory and harmonic US measurements (Table 1). Table 1 Clinical Practice Guideline Scoring System (CPGS) [1]:       1 0 Score Clinical data General – Fever Yes No       – HR > 120/min. < 120/min.       - Vomiting Yes No       - Dehydration Yes No     Abdominal Abd. pain           - Localized Yes No       - History of similar - attacks No Yes       - Character Constant Intermittent       - Severity Intolerable Tolerable       - Course Progressive Regressive    

  – Relief by antispasmodic No RO4929097 Yes       – Bowel Habit alteration Yes No       – Rebound tenderness Yes (3) No       – Guarding or rigidity Yes No       – +ve P.R. examination Yes No   Investigations Laboratory – WBCs leukocytosis Yes No       – Urine analysis (Findings of UTI) Yes No     Focused abdominal U.S. – Appendicitis or mass Yes No       – +ve findings in female Adnxae No Yes       – +ve findings in liver, Gall bladder, billiary passages No Yes       – +ve findings kidneys No Yes       – Free fluid Yes No   Total score   Interpretation of results: 21 – 15 = highly suggestive of appendicitis. 14 – 8 = Patient needs repeated evaluation for conclusive C188-9 result. 7 – 0 = the diagnosis of acute appendicitis in not Adenosine likely. Two hundred sixty five (265) pediatric patients were the core of

our current study. In those patients; the proposed usage of THI, clinical judgment and practice as a modified score aided system MCPGS was applied. The MCPGS with twenty five variables including harmonic ultrasound (US) examination and a marker of inflammatory response was assessed in multivariate analysis using the finding of acute appendicitis at operation as the end point were enrolled in this study (Table 2). Exclusion criteria included those who were proved to have other causes of acute abdominal pain rather than acute appendicitis. Table 2 Modified clinical practice and harmonic ultrasonographic grading score (MCPGS):       1 0 Score Clinical data General – Fever Yes No       – HR > 120/min. < 120/min.       – Vomiting Yes No     Abdominal Abd.

24. Gotovac S, Yang C-M, Hattori Y, Takahashi K, Kanoh H, Kaneko K: Adsorption of polyaromatic hydrocarbons on single wall carbon nanotubes of different functionalities selleck chemical and diameters. J Colloid Interface Sci 2007, 314:18–24. 25. Long RQ, Yang RT: Carbon nanotubes as superior sorbent for dioxin removal. J Am Chem Soc 2001, 123:2058–2059. 26. Lu C, Chung Y-L, Chang K-F: Adsorption thermodynamic

and kinetic studies of trihalomethanes on multiwalled carbon nanotubes. J Hazard Mater 2006, 138:304–310. 27. Peng X, Li Y, Luan Z, Di Z, Wang H, Tian B, Jia Z: Adsorption of 1,2-dichlorobenzene from water to carbon nanotubes. Chem Phys Lett 2003, 376:154–158. 28. Upadhyayula VK, Deng S, Mitchell MC, Smith GB: Application of carbon nanotube technology for removal of contaminants in drinking water: a review. Sci Total Environ 2009, 408:1–13. 29. Yang K, Zhu L, Xing B: Adsorption of polycyclic aromatic hydrocarbons by carbon nanomaterials. Environ Sci Technol 2006, 40:1855–1861. 30. Zhang S, Shao T, Kose HS, Karanfil T: Adsorption of aromatic compounds by carbonaceous adsorbents: a comparative study on granular activated carbon, activated carbon fiber, and carbon nanotubes. Environ Sci Technol 2010, 44:6377–6383. 31. Zhang S, Shao T, Kose HS,

Karanfil T: Adsorption kinetics of aromatic compounds on carbon nanotubes and activated carbons. Environ Toxicol Chem 2012, 31:79–85. 32. Savage N, Diallo MS: Nanomaterials and water purification: opportunities and challenges. J Nanopart Res 2005, 7:331–342. 33. Di Z-C, Ding J, Peng X-J, Li Y-H, Luan Z-K, Liang J: Chromium adsorption buy CYT387 by aligned carbon nanotubes supported ceria nanoparticles. Chemosphere 2006, 62:861–865. 34. Li Y-H, Di Z, Ding J, Wu D, Luan Z, Zhu Y: Adsorption WZB117 cell line thermodynamic, kinetic and desorption studies

of Pb 2+ on carbon nanotubes. Water Res 2005, 39:605–609. 35. Rao GP, Lu C, Su F: Sorption of divalent metal ions from aqueous solution by carbon nanotubes: a review. Sep Purif Technol 2007, 58:224–231. 36. Peng X, Luan Z, Ding J, Di Z, Li Y, Tian B: Ceria nanoparticles supported on carbon nanotubes for the removal of arsenate from water. Mater Lett 2005, 59:399–403. 37. Yan X, Shi B, Lu J, Feng C, Wang D, Tang H: Adsorption Erastin manufacturer and desorption of atrazine on carbon nanotubes. J Colloid Interface Sci 2008, 321:30–38. 38. Akasaka T, Watari F: Capture of bacteria by flexible carbon nanotubes. Acta Biomater 2009, 5:607–612. 39. Deng J, Yu L, Liu C, Yu K, Shi X, Yeung LWY, Lam PKS, Wu RSS, Zhou B: Hexabromocyclododecane-induced developmental toxicity and apoptosis in zebrafish embryos. Aquat Toxicol 2009, 93:29–36. 40. Upadhyayula VK, Deng S, Smith GB, Mitchell MC: Adsorption of Bacillus subtilis on single-walled carbon nanotube aggregates, activated carbon and NanoCeram™. Water Res 2009, 43:148–156. 41. Brady‒Estévez AS, Kang S, Elimelech M: A single‒walled‒carbon‒nanotube filter for removal of viral and bacterial pathogens. Small 2008, 4:481–484. 42.